Amendment to PAR-07-214: Academic-Industrial Partnerships for Development and Validation of In Vivo Imaging Systems and Methods for Cancer Investigations (R01)

Notice Number: NOT-CA-08-014

Key Dates
Release Date:  March 13, 2008

Issued by
National Cancer Institute (NCI) (http://www.cancer.gov/)

Purpose

The purpose of this Notice is to announce a change in PAR-07-214, Academic-Industrial Partnerships for Development and Validation of In Vivo Imaging Systems and Methods for Cancer Investigations (R01).  Academic-industrial partnership R01 awards are now eligible for renewals at the appropriate times; thus, the NCI will accept eligible renewal (Type 2) R01 applications for grants made in connection with PAR-07-214.

Inquiries

Direct inquiries regarding this Notice to your NCI Program Director or to:

Guoying Liu, Ph.D.
Cancer Imaging Program
National Cancer Institute
6130 Executive Boulevard, EPN Suite 6000, MSC 7412
Bethesda, MD 20892-7412 (for U.S. Postal Service express or regular mail)
Bethesda, MD 20852 (for non-USPS delivery)
Telephone: 301-496-9531
Fax: 301-480-3507
E-mail: liug@mail.nih.gov